temanogrel hydrochloride
Term · Oncology and biomedicine · MLC-T-ONC-017059
The hydrochloride salt form of temanogrel, an orally bioavailable, selective inverse agonist of 5-hydroxytryptamine receptor 2A (5-HT2A), with potential anti-thrombotic and vasodilating activities. Upon oral administration, temanogrel targets, binds to and inhibits 5-HT2A expressed on platelet surfaces and in smooth muscle cells, thereby inhibiting 5-HT-mediated platelet aggregation and vasoconstriction. This may attenuate platelet aggregation and vasoconstriction, and improve blood flow.
| Identifier | MLC-T-ONC-017059 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Temanogrel |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017059",
"term": "temanogrel hydrochloride",
"field": "Oncology and biomedicine",
"definition": "The hydrochloride salt form of temanogrel, an orally bioavailable, selective inverse agonist of 5-hydroxytryptamine receptor 2A (5-HT2A), with potential anti-thrombotic and vasodilating activities. Upon oral administration, temanogrel targets, binds to and inhibits 5-HT2A expressed on platelet surfaces and in smooth muscle cells, thereby inhibiting 5-HT-mediated platelet aggregation and vasoconstriction. This may attenuate platelet aggregation and vasoconstriction, and improve blood flow.",
"synonyms": [
"Temanogrel"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/temanogrel-hydrochloride/"
}
Record 16,131 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.